Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 21416583 | HLA MISMATCHED (HLA-MISMATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| the impact of graft composition on clinical outcomes in pediatric patients undergoing unmanipulated hla-mismatched/haploidentical hematopoietic stem cell transplantation. | |||||||
| 21416583 | HLA MISMATCHED (HLA-MISMATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | only_studied | |
| we examined the absolute numbers and relative proportions of cd3+, cd4+, cd8+, cd14+, and cd34+ cells contained in allografts of 103 children who underwent unmanipulated hla-mismatched/haploidentical hematopoietic stem cell transplantation (hsct) without in vitro t cell depletion. | |||||||
| 21431504 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | lenalidomide | NA | negation | |
| there are many options for the management of mds, but the only potentially curative treatment is allogenic hematopoietic stem cell transplantation (allo-hsct), which is often not an option because of advanced age or comorbidities at diagnosis or lack of a human leukocyte antigen-identical donor. | |||||||
| 21457147 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| human leukocyte antigen (hla) high-resolution matching is routinely performed in the case of hematopoietic stem cell transplantation. | |||||||
| 21530531 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| histocompatibility testing has been used in support of solid organ and hematopoietic stem cell transplantation for over fifty years and transplantation has clearly served as a major stimulus for interest in the human major histocompatibility complex, the hla system. | |||||||
| 21536142 | HLA-A (HLA-A) | hematopoietic stem cell transplantation | Caucasian | NA | NA | unclassified | |
| contribution of hla-a/b/c/drb1/dqb1 common haplotypes to donor search outcome in unrelated hematopoietic stem cell transplantation. | |||||||
| 21536142 | HLA-DRB1 (HLA-DRB1) | hematopoietic stem cell transplantation | Caucasian | NA | NA | unclassified | |
| contribution of hla-a/b/c/drb1/dqb1 common haplotypes to donor search outcome in unrelated hematopoietic stem cell transplantation. | |||||||
| 21536142 | HLA-DQB1 (HLA-DQB1) | hematopoietic stem cell transplantation | Caucasian | NA | NA | unclassified | |
| contribution of hla-a/b/c/drb1/dqb1 common haplotypes to donor search outcome in unrelated hematopoietic stem cell transplantation. | |||||||
| 21567370 | HLA IDENTICAL (HLA-IDENTICAL) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| for thrombasthenia glanzmann (gt) patients presenting with a severe clinical phenotype due to complete lack of thrombocyte function or increased titres of anti-platelet antibodies hematopoietic stem cell transplantation (sct) is the only curative therapy.case reportwe report the case of a 13-month-old boy, presenting with a severe course of gt, who was successfully treated with an hla-identical sibling bone marrow transplant. | |||||||
| 21567370 | HLA IDENTICAL (HLA-IDENTICAL) | thrombasthenia glanzmann | NA | NA | NA | unclassified | |
| for thrombasthenia glanzmann (gt) patients presenting with a severe clinical phenotype due to complete lack of thrombocyte function or increased titres of anti-platelet antibodies hematopoietic stem cell transplantation (sct) is the only curative therapy.case reportwe report the case of a 13-month-old boy, presenting with a severe course of gt, who was successfully treated with an hla-identical sibling bone marrow transplant. | |||||||
Copyright 2024